|
ZNRF2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62447832963153E-12 |
| Normal-vs-Stage2 |
5.837500E-03 |
| Normal-vs-Stage3 |
1.72983849466846E-12 |
| Normal-vs-Stage4 |
8.43580760800933E-12 |
| Stage1-vs-Stage2 |
5.539200E-03 |
| Stage1-vs-Stage3 |
3.009000E-01 |
| Stage1-vs-Stage4 |
5.340000E-01 |
| Stage2-vs-Stage3 |
4.330500E-02 |
| Stage2-vs-Stage4 |
3.683600E-02 |
| Stage3-vs-Stage4 |
7.133000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
5.62439999999276E-05 |
| Normal-vs-Asian |
2.66479949218024E-10 |
| Caucasian-vs-AfricanAmerican |
3.001600E-01 |
| Caucasian-vs-Asian |
7.673200E-01 |
| AfricanAmerican-vs-Asian |
4.792800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.80133685745432E-12 |
| Normal-vs-Female |
<1E-12 |
| Male-vs-Female |
2.259000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
<1E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
4.93299999737573E-08 |
| Normal-vs-Age(81-100Yrs) |
2.758100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.228100E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.316610E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.724000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.325600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.344000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.182800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.355800E-01 |
| Classical-VS-Follicular |
4.49199566432412E-11 |
| Classical-VS-Other |
2.652600E-01 |
| Classical-VS-Normal |
<1E-12 |
| Tall-VS-Follicular |
1.524100E-03 |
| Tall-VS-Other |
5.122600E-01 |
| Tall-VS-Normal |
3.2241000003097E-07 |
| Follicular-VS-Other |
2.757800E-01 |
| Follicular-VS-Normal |
9.676800E-03 |
| Other-VS-Normal |
9.747900E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.64646074551911E-13 |
| Normal-vs-N1 |
1.45439216225896E-13 |
| N0-vs-N1 |
2.975400E-03 |
|
|
